Global Tendonitis Treatment Market Size, Share & Industry Trends Analysis Report By Type (Therapy and Surgery), By Therapy Type (Physical Therapy, Hot & Cold Therapy and Shockwave Therapy), By Condition, By Regional Outlook and Forecast, 2022 - 2028

Report
221 Pages
November 2022
Region: Global
Marqual IT Solutions Pvt. Ltd (KBV Research)
ID: 5709459

The Global Tendonitis Treatment Market size is expected to reach $252.3 billion by 2028, rising at a market growth of 3.7% CAGR during the forecast period.

When the tendons - a flexible but inelastic cord of tissue linking the bone to the muscle become inflamed or irritated, the disease is referred to as tendonitis. Pain, loss of movement, and inflammation from tendonitis are just a few of the issues that can result from this disease. Mild swelling, frozen shoulder, and discomfort are a few of the signs of tendonitis.

Although a sudden injury might result in tendinitis, the condition is far more likely to develop by repeatedly performing a certain movement over time. Most tendinitis cases are brought on by repetitive motions from work or hobbies that strain the tendons. It's crucial to use good technique when engaging in repetitive work- or sports-related activities. Tennis elbow is one example of how improper technique can overload the tendon and cause tendonitis.

Pain relief and inflammation reduction are the goals of tendinitis treatment. Common home remedies include rest, heat and ice packs, and over-the-counter painkillers. Further measures may be suggested by a doctor if they do not help a person's symptoms.

A result of overuse is tendinitis. The inflammation can be reduced by giving the injured tendon some rest. The person should refrain from the sport or repetitive motion that triggered the tendonitis. Movement can be limited with the aid of a bandage, splint, or brace.

COVID-19 Impact Analysis

The pandemic had an impact on the major players' supply chains, operations, product distribution, production, and other commercial ventures. Many businesses in the industry have reported a reduction in sales of their tendonitis treatment goods. The healthcare facilities were compelled to reschedule and prioritize treatments as important or not due to factors such as a lack of Personal Protective Equipment (PPE), a skilled workforce, restrictions, and lockdowns. A reduction in market growth during the pandemic can be linked to the fact that various physical therapy and surgical techniques for tendonitis treatment were not deemed necessary during the pandemic period. This will provide positive growth prospects in the upcoming years.

Market Growth Factors

Rising Incidence Of Sport Injury

The rise in amateur sports and activity levels, and the ageing of the population in key markets around the world, are all predicted to increase demand for high-end treatment of tendonitis. Tendonitis is typically brought on by the overuse or repetitive stress of tendons in the knee, wrist, or ankle. Due to this, tendonitis is the most common injury afflicting participants in high-demand sports including basketball, football, downhill skiing, gymnastics, and soccer.

Growing Cases Of Orthopedic Disorders

Orthopedic injuries are a key reason for concern in terms of public health as the prevalence of serious orthopedic diseases is increasing globally. Some of the factors contributing to this cause of concern are the rising prevalence of tennis elbow, pitcher’s elbow, swimmer’s shoulder, and Achilles tendonitis. Another crucial sign is the rise in the number of obese persons in the world. Obese people are much more likely to acquire diabetes, as well as orthopedic and musculoskeletal conditions.

Market Restraining Factors

Severe Impact Of Pandemic Period

The tendonitis treatment market is being hampered by recurring injuries, delay, and the ineffectiveness of treatments, along with the associated side effects. The Covid-19 outbreak has had a profound impact on how tendinitis is managed. Temporary lockdowns, travel restrictions, and an increase in the number of infections in healthcare facilities have all had a negative influence on the industry. Due to a shortage of skilled healthcare professionals who can treat tendinitis, the epidemic has been delayed.

Type Outlook

Based on type, the tendonitis treatment market is segmented into therapy (hot & cold therapy, physical therapy, shockwave therapy) and surgery. The surgery segment acquired a significant revenue share in the tendonitis treatment market in 2021. For severely injured tendons that are unresponsive to pharmacological therapy, surgical operations are the last resort in the treatment strategy.

Condition Outlook

On the basis of condition, the tendonitis treatment market is fragmented into tennis elbow, golfer’s elbow, pitcher’s elbow, jumper’s knee, swimmer’s shoulder and achilles tendonitis. In 2021, the Achilles tendonitis segment witnessed the highest revenue share in the tendonitis treatment market. The largest tendon in the human body is the Achilles tendon. Running and jumping can stretch and rupture the Achilles tendon, which results in tendinitis. A large number of people are affected by Achilles tendinitis, and most of the ruptures happen when engaging in recreational sports.

Regional Outlook

Region wise, the tendonitis treatment market is analyzed across the North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region led the tendonitis treatment market by generating the largest revenue share. The few elements that contribute to the region's growth include an increase in the number of tendonitis procedures performed there and rising consumer disposable income levels. Significant growth potential for the industry in the region is being created by the introduction of local medical device manufacturers and partnerships with established & famous firms.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Merck & Co., Inc., Bayer AG, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Abbott Laboratories, Pfizer, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., and Almatica Pharma, Inc.

Strategies Deployed in Tendonitis Treatment Market

Partnerships, Collaborations and Agreements:

Aug-2020: Teva came into a partnership with Alvotech, a global biopharmaceutical company focused on the development & manufacturing of high-quality biosimilars for worldwide markets. This partnership would enable Teva to lend its technical expertise in working with the FDA to bring products to the U.S. market along with broadening its growing biosimilar portfolio as well as continuing to leverage its exceptional cross-functional expertise across both specialty & generic medicines.

Product Launches and Product Expansions:

Apr-2022: Boehringer Ingelheim introduced RenuTend, a new stem cell therapy. This therapy enhances the healing of tendon & suspensory ligament injuries in horses. The therapy further demonstrates the company's commitment to bringing innovation with the aim to enhance the lives of horses and the people who love them.

Approvals and Trials:

Aug-2022: Abbott got FDA approval for Proclaim Plus, a spinal cord stimulation system featuring FlexBurst360 therapy. FlexBurst360 therapy would offer pain coverage across up to six areas of the trunk and/or limbs & allow programming that could be adjusted as a person's therapeutic demands evolve. Through Proclaim Plus, the company aimed to address its commitment to advancing the field of neurostimulation and helping people address the challenges they face while managing their chronic pain.

Acquisitions and Mergers:

Oct-2022: Pfizer acquired Biohaven Pharmaceuticals, a commercial-stage biopharmaceutical company. This acquisition focused on growing Pfizer's potential to bring the latest treatment options to patients with migraine.
Oct-2022: Pfizer completed the acquisition of Global Blood Therapeutics, a biopharmaceutical company dedicated to the discovery, development, and delivery of life-changing treatments. With this acquisition, Pfizer focused on accelerating innovation & expeditiously bringing multiple potential best-in-class treatments to people living with sickle cell disease.
Jun-2022: Boehringer Ingelheim took over Trutino Biosciences, a pre-clinical stage biotech company. This acquisition would advance the company’s effort to mobilize a patient’s immune system and fight cancer through cancer cell-directed and immune cell-targeting compounds. Further, under this acquisition, Boehringer Ingelheim reserves the right to buy all shares of Trutino Biosciences once specified program milestones have been achieved within a specified time period. Trutino would continue to operate as an independent company until that time.
Apr-2022: GSK completed the acquisition of Sierra Oncology, a California-based, late-stage Biopharmaceutical Company. Through this acquisition, GSK would get the opportunity to bring meaningful latest benefits to patients and further strengthen its portfolio of specialty medicines.
Mar-2022: Pfizer took over Arena Pharmaceuticals, an American biopharmaceutical company. Addition of Arena Pharmaceuticals's experience and pipeline to Pfizer’s Inflammation and Immunology therapeutic area, helping them to develop breakthroughs to change the lives of people with immuno-inflammatory diseases.
Nov-2021: Pfizer took over Trillium Therapeutics, a clinical stage immuno-oncology company. This acquisition aimed at enabling Pfizer to accelerate breakthroughs that change patients’ lives.
Jul-2021: AstraZeneca took over Alexion Pharmaceuticals, an American pharmaceutical company. This acquisition would mark the Company’s entry into medicines for rare diseases and the beginning of the latest chapter for AstraZeneca.
Nov-2020: Merck took over OncoImmune, a privately-held, clinical-stage Biopharmaceutical Company. By this acquisition, Merck would be able to access CD24Fc and take advantage beyond the standard of care therapy for COVID-19 patients requiring oxygen support and hence would represent an important addition to the Merck pipeline of investigational medicines & vaccines developed to address the COVID-19pandemic.

Scope of the Study

By Type

Therapy
- Physical Therapy
- Hot & Cold Therapy
- Shockwave Therapy
Surgery

By Condition

Achilles Tendonitis
Jumper’s Knee
Tennis Elbow
Pitcher’s Elbow
Swimmer’s Shoulder
Golfer’s Elbow

By Geography

North America
US
Canada
Mexico
Rest of North America

Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Asia Pacific
China
Japan
India
South Korea
Singapore
Australia
Rest of Asia Pacific

LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

Merck & Co., Inc.
Bayer AG
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Abbott Laboratories
Pfizer, Inc.
GlaxoSmithKline PLC
Teva Pharmaceuticals Industries Ltd.
Almatica Pharma, Inc.

Unique Offerings

Exhaustive coverage
The highest number of Market tables and figures
Subscription-based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Tendonitis Treatment Market, by Type
1.4.2 Global Tendonitis Treatment Market, by Condition
1.4.3 Global Tendonitis Treatment Market, by Geography
1.5 Research Methodology

Chapter 2. Market Overview

2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Recent Strategies Deployed in Tendonitis Treatment Market

Chapter 4. Global Tendonitis Treatment Market by Type

4.1 Global Therapy Market by Region
4.2 Global Tendonitis Treatment Market by Therapy Type
4.2.1 Global Physical Therapy Market by Region
4.2.2 Global Hot & Cold Therapy Market by Region
4.2.3 Global Shockwave Therapy Market by Region
4.3 Global Surgery Market by Region

Chapter 5. Global Tendonitis Treatment Market by Condition

5.1 Global Achilles Tendonitis Market by Region
5.2 Global Jumper’s Knee Market by Region
5.3 Global Tennis Elbow Market by Region
5.4 Global Pitcher’s Elbow Market by Region
5.5 Global Swimmer’s Shoulder Market by Region
5.6 Global Golfer’s Elbow Market by Region

Chapter 6. Global Tendonitis Treatment Market by Region

6.1 North America Tendonitis Treatment Market
6.1.1 North America Tendonitis Treatment Market by Type
6.1.1.1 North America Therapy Market by Country
6.1.1.2 North America Tendonitis Treatment Market by Therapy Type
6.1.1.2.1 North America Physical Therapy Market by Country
6.1.1.2.2 North America Hot & Cold Therapy Market by Country
6.1.1.2.3 North America Shockwave Therapy Market by Country
6.1.1.3 North America Surgery Market by Country
6.1.2 North America Tendonitis Treatment Market by Condition
6.1.2.1 North America Achilles Tendonitis Market by Country
6.1.2.2 North America Jumper’s Knee Market by Country
6.1.2.3 North America Tennis Elbow Market by Country
6.1.2.4 North America Pitcher’s Elbow Market by Country
6.1.2.5 North America Swimmer’s Shoulder Market by Country
6.1.2.6 North America Golfer’s Elbow Market by Country
6.1.3 North America Tendonitis Treatment Market by Country
6.1.3.1 US Tendonitis Treatment Market
6.1.3.1.1 US Tendonitis Treatment Market by Type
6.1.3.1.1.1 US Tendonitis Treatment Market by Therapy Type
6.1.3.1.2 US Tendonitis Treatment Market by Condition
6.1.3.2 Canada Tendonitis Treatment Market
6.1.3.2.1 Canada Tendonitis Treatment Market by Type
6.1.3.2.1.1 Canada Tendonitis Treatment Market by Therapy Type
6.1.3.2.2 Canada Tendonitis Treatment Market by Condition
6.1.3.3 Mexico Tendonitis Treatment Market
6.1.3.3.1 Mexico Tendonitis Treatment Market by Type
6.1.3.3.1.1 Mexico Tendonitis Treatment Market by Therapy Type
6.1.3.3.2 Mexico Tendonitis Treatment Market by Condition
6.1.3.4 Rest of North America Tendonitis Treatment Market
6.1.3.4.1 Rest of North America Tendonitis Treatment Market by Type
6.1.3.4.1.1 Rest of North America Tendonitis Treatment Market by Therapy Type
6.1.3.4.2 Rest of North America Tendonitis Treatment Market by Condition
6.2 Europe Tendonitis Treatment Market
6.2.1 Europe Tendonitis Treatment Market by Type
6.2.1.1 Europe Therapy Market by Country
6.2.1.2 Europe Tendonitis Treatment Market by Therapy Type
6.2.1.2.1 Europe Physical Therapy Market by Country
6.2.1.2.2 Europe Hot & Cold Therapy Market by Country
6.2.1.2.3 Europe Shockwave Therapy Market by Country
6.2.1.3 Europe Surgery Market by Country
6.2.2 Europe Tendonitis Treatment Market by Condition
6.2.2.1 Europe Achilles Tendonitis Market by Country
6.2.2.2 Europe Jumper’s Knee Market by Country
6.2.2.3 Europe Tennis Elbow Market by Country
6.2.2.4 Europe Pitcher’s Elbow Market by Country
6.2.2.5 Europe Swimmer’s Shoulder Market by Country
6.2.2.6 Europe Golfer’s Elbow Market by Country
6.2.3 Europe Tendonitis Treatment Market by Country
6.2.3.1 Germany Tendonitis Treatment Market
6.2.3.1.1 Germany Tendonitis Treatment Market by Type
6.2.3.1.1.1 Germany Tendonitis Treatment Market by Therapy Type
6.2.3.1.2 Germany Tendonitis Treatment Market by Condition
6.2.3.2 UK Tendonitis Treatment Market
6.2.3.2.1 UK Tendonitis Treatment Market by Type
6.2.3.2.1.1 UK Tendonitis Treatment Market by Therapy Type
6.2.3.2.2 UK Tendonitis Treatment Market by Condition
6.2.3.3 France Tendonitis Treatment Market
6.2.3.3.1 France Tendonitis Treatment Market by Type
6.2.3.3.1.1 France Tendonitis Treatment Market by Therapy Type
6.2.3.3.2 France Tendonitis Treatment Market by Condition
6.2.3.4 Russia Tendonitis Treatment Market
6.2.3.4.1 Russia Tendonitis Treatment Market by Type
6.2.3.4.1.1 Russia Tendonitis Treatment Market by Therapy Type
6.2.3.4.2 Russia Tendonitis Treatment Market by Condition
6.2.3.5 Spain Tendonitis Treatment Market
6.2.3.5.1 Spain Tendonitis Treatment Market by Type
6.2.3.5.1.1 Spain Tendonitis Treatment Market by Therapy Type
6.2.3.5.2 Spain Tendonitis Treatment Market by Condition
6.2.3.6 Italy Tendonitis Treatment Market
6.2.3.6.1 Italy Tendonitis Treatment Market by Type
6.2.3.6.1.1 Italy Tendonitis Treatment Market by Therapy Type
6.2.3.6.2 Italy Tendonitis Treatment Market by Condition
6.2.3.7 Rest of Europe Tendonitis Treatment Market
6.2.3.7.1 Rest of Europe Tendonitis Treatment Market by Type
6.2.3.7.1.1 Rest of Europe Tendonitis Treatment Market by Therapy Type
6.2.3.7.2 Rest of Europe Tendonitis Treatment Market by Condition
6.3 Asia Pacific Tendonitis Treatment Market
6.3.1 Asia Pacific Tendonitis Treatment Market by Type
6.3.1.1 Asia Pacific Therapy Market by Country
6.3.1.2 Asia Pacific Tendonitis Treatment Market by Therapy Type
6.3.1.2.1 Asia Pacific Physical Therapy Market by Country
6.3.1.2.2 Asia Pacific Hot & Cold Therapy Market by Country
6.3.1.2.3 Asia Pacific Shockwave Therapy Market by Country
6.3.1.3 Asia Pacific Surgery Market by Country
6.3.2 Asia Pacific Tendonitis Treatment Market by Condition
6.3.2.1 Asia Pacific Achilles Tendonitis Market by Country
6.3.2.2 Asia Pacific Jumper’s Knee Market by Country
6.3.2.3 Asia Pacific Tennis Elbow Market by Country
6.3.2.4 Asia Pacific Pitcher’s Elbow Market by Country
6.3.2.5 Asia Pacific Swimmer’s Shoulder Market by Country
6.3.2.6 Asia Pacific Golfer’s Elbow Market by Country
6.3.3 Asia Pacific Tendonitis Treatment Market by Country
6.3.3.1 China Tendonitis Treatment Market
6.3.3.1.1 China Tendonitis Treatment Market by Type
6.3.3.1.1.1 China Tendonitis Treatment Market by Therapy Type
6.3.3.1.2 China Tendonitis Treatment Market by Condition
6.3.3.2 Japan Tendonitis Treatment Market
6.3.3.2.1 Japan Tendonitis Treatment Market by Type
6.3.3.2.1.1 Japan Tendonitis Treatment Market by Therapy Type
6.3.3.2.2 Japan Tendonitis Treatment Market by Condition
6.3.3.3 India Tendonitis Treatment Market
6.3.3.3.1 India Tendonitis Treatment Market by Type
6.3.3.3.1.1 India Tendonitis Treatment Market by Therapy Type
6.3.3.3.2 India Tendonitis Treatment Market by Condition
6.3.3.4 Australia Tendonitis Treatment Market
6.3.3.4.1 Australia Tendonitis Treatment Market by Type
6.3.3.4.1.1 Australia Tendonitis Treatment Market by Therapy Type
6.3.3.4.2 Australia Tendonitis Treatment Market by Condition
6.3.3.5 South Korea Tendonitis Treatment Market
6.3.3.5.1 South Korea Tendonitis Treatment Market by Type
6.3.3.5.1.1 South Korea Tendonitis Treatment Market by Therapy Type
6.3.3.5.2 South Korea Tendonitis Treatment Market by Condition
6.3.3.6 Singapore Tendonitis Treatment Market
6.3.3.6.1 Singapore Tendonitis Treatment Market by Type
6.3.3.6.1.1 Singapore Tendonitis Treatment Market by Therapy Type
6.3.3.6.2 Singapore Tendonitis Treatment Market by Condition
6.3.3.7 Rest of Asia Pacific Tendonitis Treatment Market
6.3.3.7.1 Rest of Asia Pacific Tendonitis Treatment Market by Type
6.3.3.7.1.1 Rest of Asia Pacific Tendonitis Treatment Market by Therapy Type
6.3.3.7.2 Rest of Asia Pacific Tendonitis Treatment Market by Condition
6.4 LAMEA Tendonitis Treatment Market
6.4.1 LAMEA Tendonitis Treatment Market by Type
6.4.1.1 LAMEA Therapy Market by Country
6.4.1.2 LAMEA Tendonitis Treatment Market by Therapy Type
6.4.1.2.1 LAMEA Physical Therapy Market by Country
6.4.1.2.2 LAMEA Hot & Cold Therapy Market by Country
6.4.1.2.3 LAMEA Shockwave Therapy Market by Country
6.4.1.3 LAMEA Surgery Market by Country
6.4.2 LAMEA Tendonitis Treatment Market by Condition
6.4.2.1 LAMEA Achilles Tendonitis Market by Country
6.4.2.2 LAMEA Jumper’s Knee Market by Country
6.4.2.3 LAMEA Tennis Elbow Market by Country
6.4.2.4 LAMEA Pitcher’s Elbow Market by Country
6.4.2.5 LAMEA Swimmer’s Shoulder Market by Country
6.4.2.6 LAMEA Golfer’s Elbow Market by Country
6.4.3 LAMEA Tendonitis Treatment Market by Country
6.4.3.1 Brazil Tendonitis Treatment Market
6.4.3.1.1 Brazil Tendonitis Treatment Market by Type
6.4.3.1.1.1 Brazil Tendonitis Treatment Market by Therapy Type
6.4.3.1.2 Brazil Tendonitis Treatment Market by Condition
6.4.3.2 Argentina Tendonitis Treatment Market
6.4.3.2.1 Argentina Tendonitis Treatment Market by Type
6.4.3.2.1.1 Argentina Tendonitis Treatment Market by Therapy Type
6.4.3.2.2 Argentina Tendonitis Treatment Market by Condition
6.4.3.3 UAE Tendonitis Treatment Market
6.4.3.3.1 UAE Tendonitis Treatment Market by Type
6.4.3.3.1.1 UAE Tendonitis Treatment Market by Therapy Type
6.4.3.3.2 UAE Tendonitis Treatment Market by Condition
6.4.3.4 Saudi Arabia Tendonitis Treatment Market
6.4.3.4.1 Saudi Arabia Tendonitis Treatment Market by Type
6.4.3.4.1.1 Saudi Arabia Tendonitis Treatment Market by Therapy Type
6.4.3.4.2 Saudi Arabia Tendonitis Treatment Market by Condition
6.4.3.5 South Africa Tendonitis Treatment Market
6.4.3.5.1 South Africa Tendonitis Treatment Market by Type
6.4.3.5.1.1 South Africa Tendonitis Treatment Market by Therapy Type
6.4.3.5.2 South Africa Tendonitis Treatment Market by Condition
6.4.3.6 Nigeria Tendonitis Treatment Market
6.4.3.6.1 Nigeria Tendonitis Treatment Market by Type
6.4.3.6.1.1 Nigeria Tendonitis Treatment Market by Therapy Type
6.4.3.6.2 Nigeria Tendonitis Treatment Market by Condition
6.4.3.7 Rest of LAMEA Tendonitis Treatment Market
6.4.3.7.1 Rest of LAMEA Tendonitis Treatment Market by Type
6.4.3.7.1.1 Rest of LAMEA Tendonitis Treatment Market by Therapy Type
6.4.3.7.2 Rest of LAMEA Tendonitis Treatment Market by Condition

Chapter 7. Company Profiles

7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent Strategies and Developments
7.1.5.1 Approvals and Trials
7.1.6 SWOT Analysis
7.2 AstraZeneca PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent Strategies and Developments
7.2.5.1 Acquisition and Mergers
7.3 GlaxoSmithKline PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent Strategies and Developments
7.3.5.1 Acquisitions and Mergers
7.4 Merck & Co., Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent Strategies and Developments
7.4.5.1 Acquisition and Mergers
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent Strategies and Developments
7.5.5.1 Partnerships, Collaborations, and Agreements
7.6 Boehringer Ingelheim International Gmbh
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional & Segmental Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent Strategies and Developments
7.6.5.1 Product Launches and Product Expansions
7.6.5.2 Acquisition and Mergers
7.7 Bayer AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent Strategies and Developments
7.8.5.1 Acquisition and Mergers
7.9 Almatica Pharma LLC (Alvogen, Inc.)
7.9.1 Company Overview

Companies Mentioned

Merck & Co., Inc.
Bayer AG
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Abbott Laboratories
Pfizer, Inc.
GlaxoSmithKline PLC
Teva Pharmaceuticals Industries Ltd.
Almatica Pharma, Inc.

Methodology

LOADING...

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3475EUR$3,600USD£2,981GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4170EUR$4,320USD£3,577GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5838EUR$6,048USD£5,007GBP